whatshot

RZLT   $4.75  -4.04% Market Closed After Close 4.7 -1.05%

Rezolute Inc
show_chart Advanced Chart of RZLT
Last Events:

2023-08-09 Trend pattern changed from расширяющаяся формация to расходящийся треугольник.

2023-08-09 Trend Power changed from almost flat to slow.

2023-08-09 Trend changed from turning up to down and flat.

2023-08-06 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-05 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-04 Signal in Stochastic changed from bullish reversal to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

2023-08-03 Signal in MACD changed from bearish weakening to bearish recovery. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: main and signal line crossing.

2023-08-03 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

Current temperature: 5.24
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 8
Target Price Mean 12.75
Mean unverified/preliminary 12.75 / 12.75
Target Price Low / High 7.00 / 15.00
Median / STD DEV 13.50 / 2.60
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy Buy
rsi Sell ActivelyBuy ActivelyBuy
macd None None None
stoch None None None
ma20 Sell Buy None
ma50 None None None
ma100 Buy ActivelyBuy None
Candlestick PatternOct. 14, 2024 Three Stars -
ISIN US76200L3096
ceo Mr. Nevan Charles Elam J.D.
Website https://www.rezolutebio.com
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.